SEC Form 4 · accession 0001144204-16-138799
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Podolski
Officer — President and CEO · Director
Period of report
Dec 9, 2016
Accepted (ET)
Dec 9, 2016 · 5:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 9, 2016 | P | 20,000 | $1.60 | A | 107,422 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F175 shares are owned by certain family members of the reporting person.